» Articles » PMID: 28542279

Oligopeptides As Full-length New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors

Overview
Journal PLoS One
Date 2017 May 26
PMID 28542279
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

'Superbug' bacteria producing NDM-1 enzyme causing wide public concern were first detected in a patient who visited India in 2008. It's an effective approach to combining β-lactam antibiotics with NDM-1 inhibitor for treating NDM-1 producing strain infection. In our research, we designed ten oligopeptides, tested IC50 values against NDM-1 enzyme, determined the MIC values of synergistic antibacterial effect and explored the binding model. We found that the oligopeptides 2 (Cys-Phe) and 5 (Cys-Asp) respectively presented IC50 values of 113 μM and 68 μM and also displayed favorable synergistic effects of the inhibitors in combination with ertapenem against genetic engineering-host E. coli BL21 (DE3)/pET30a-NDM-1 and a clinical isolate of P. aeruginosa with blaNDM-1. Flexible docking and partial charge study suggested the interaction between oligopeptide and NDM-1. Three types of action effects, hydrogen bond, electrostatic effect and π-π interaction, contributed to the inhibitory activities.

Citing Articles

Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.

Cheng Q, Zeng P, Chan E, Chen S Curr Pharm Des. 2022; 28(44):3538-3545.

PMID: 36177630 DOI: 10.2174/1381612828666220929154255.


β-lactam/β-lactamase inhibitor combinations: an update.

Tehrani K, Martin N Medchemcomm. 2018; 9(9):1439-1456.

PMID: 30288219 PMC: 6151480. DOI: 10.1039/c8md00342d.

References
1.
Nix D, Majumdar A, DiNubile M . Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother. 2004; 53 Suppl 2:ii23-8. DOI: 10.1093/jac/dkh205. View

2.
Samuelsen O, Castanheira M, Walsh T, Spencer J . Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family. Antimicrob Agents Chemother. 2008; 52(8):2905-8. PMC: 2493091. DOI: 10.1128/AAC.00166-08. View

3.
Musson D, Birk K, Kitchen C, Zhang J, Hsieh J, Fang W . Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 783(1):1-9. DOI: 10.1016/s1570-0232(02)00240-4. View

4.
Giedraitiene A, Vitkauskiene A, Naginiene R, Pavilonis A . Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas). 2011; 47(3):137-46. View

5.
Bush K, Jacoby G, Medeiros A . A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6):1211-33. PMC: 162717. DOI: 10.1128/AAC.39.6.1211. View